MAX

MediaAlpha, Inc. Q3 2025 10-Q Summary

Business Context and Reporting Period

This summary covers MediaAlpha, Inc.'s (NYSE: MAX) quarterly report on Form 10-Q for the period ended September 30, 2025. MediaAlpha operates a technology platform facilitating customer acquisition for insurance carriers (Demand Partners) and monetization for insurance-focused websites (Supply Partners). The company operates primarily in Property & Casualty (P&C), Health, and Life insurance verticals.

Key Financial Metrics

Note: Q3 2025 Net Income includes a $38.0M legal reserve increase for the FTC matter, which was excluded from Adjusted EBITDA.

Material Changes vs. Prior Period

• Revenue Growth: Q3 2025 revenue increased 18.3% year-over-year, driven by a 31.4% surge in P&C insurance revenue due to increased carrier marketing spend. This was partially offset by a 60.9% decline in Health insurance revenue.
• Profitability: Q3 2025 Net Income rose 48.4% to $17.6M, aided by lower interest expense and higher interest income. However, the nine-month period resulted in a net loss of $7.2M due to a $13.4M write-off of intangible assets and significant legal reserves.
• Vertical Shifts: The company scaled back the under-65 Health sub-vertical to address regulatory concerns, reducing revenue in that segment from $26.7M in Q3 2024 to $9.0M in Q3 2025. The company also fully exited the Travel vertical.
• Transaction Value: Total Transaction Value on the platform increased 30.4% to $589.3M in Q3 2025, with P&C accounting for 93.0% of the total.

Guidance, Outlook, and Risks

• FTC Settlement: The company reached a Consent Order with the FTC to resolve allegations regarding deceptive advertising and telemarketing practices. The settlement requires a $45.0 million payment ($33.5M paid in October 2025; $11.5M due January 2026) and mandates operational changes, including transferring inactive under-65 health domains and implementing stricter compliance protocols.
• Share Repurchases: In September 2025, the company repurchased 3.2M shares from Insignia Capital Group for $32.9M. In October 2025, the Board authorized a new $50 million share repurchase program expected to run through 2026.
• Debt Management: In August 2025, the company amended its 2021 Credit Facilities, extending the maturity of $138.1M of term loans and $4.6M of revolver commitments to July 2027. Approximately $13.3M of term loans remain due in July 2026.
• Outlook: Management expects continued momentum in P&C due to carrier profitability but anticipates reduced revenue from the under-65 Health vertical for the remainder of 2025. The company believes current liquidity is sufficient to meet obligations for the next 12 months.
• Risks: Key risks include the cyclical nature of the insurance industry (potential "hard market" conditions due to tariffs on auto parts), regulatory changes, and reliance on a limited number of partners (two customers accounted for 53% of Q3 revenue).

Investor Verification Checklist

• FTC Settlement Impact: Verify the operational impact of the Consent Order on the Health vertical and the timing of the remaining $11.5M payment.
• Intangible Asset Write-off: Review the $13.4M write-off of assets from the Customer Helper Team acquisition to understand the scope of non-recurring charges.
• Debt Maturity Profile: Confirm the refinancing strategy for the $13.3M term loan portion maturing in July 2026.
• Customer Concentration: Assess the risk associated with two customers representing over 50% of revenue.
• Tax Valuation Allowance: Monitor the potential release of the $127.5M valuation allowance on deferred tax assets, which could materially impact future net income if profitability is sustained.